The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Increasing incidence of cancer followed by awareness for early diagnosis, growing investments in research and development of cancer biomarkers, ...
read more
The advancement path of the global pharmaceutical glass packaging market will be carved promisingly at a CAGR of 9.5%, enabling the market growth ...
read more
Phosphorex, an Ampersand Capital Partners company and drug delivery-focused contract development and manufacturing organization ("CDMO"), announced ...
read more
Harmony Biosciences (Nasdaq: HRMY), today announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth strategy by adding a rare ...
read more
TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza. This agreement with Lonza strengthens TriLink’s objective ...
read more
The FDA announced it will host a listening session in June as part of its broader work to optimize the use of, and processes for, advisory committees....
read more
Pfizer Inc. and Genmab A/S announced that the FDA approved the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (...
read more
The FDA has taken action aimed at helping to ensure the safety and effectiveness of laboratory developed tests, or LDTs, which are used in a growing ...
read more
Abbott announced that the FDA approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation ...
read more
Amgen announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a ...
read more
Lonza announced the launch of its AI-enabled Route Scouting Service offering. The offering aims to streamline synthetic route identification for novel...
read more
AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been recommended for approval in the European Union (EU) for the ...
read more
Ractigen Therapeutics, announced that the FDA approved the company's Investigational New Drug (IND) application for RAG-01, a groundbreaking saRNA ...
read more
Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to ...
read more
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (...
read more